Top compounds associated with response to ITLN1


Feature Type Standardized
Nominal ANOVA
mRNA XMD14-99 GDSC1000 pan-cancer AAC 0.054 0.1
mRNA silmitasertib CTRPv2 pan-cancer AAC -0.059 0.1
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.049 0.1
mRNA TPCA-1 CTRPv2 pan-cancer AAC 0.05 0.1
mRNA foretinib CTRPv2 pan-cancer AAC -0.054 0.1
mRNA NSC 74859 CTRPv2 pan-cancer AAC 0.058 0.1
mRNA pluripotin CTRPv2 pan-cancer AAC -0.053 0.1
mRNA AZD6244 UHNBreast pan-cancer AAC 0.45 0.1
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.1
mRNA tivantinib CTRPv2 pan-cancer AAC -0.066 0.1
Download CSV